BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 7804152)

  • 1. Mumps and rubella consensus conference.
    Can Commun Dis Rep; 1994 Oct; 20(19):165-76. PubMed ID: 7804152
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of MMR vaccine on mumps infection in England and Wales.
    Jones AG; White JM; Begg NT
    CDR (Lond Engl Rev); 1991 Aug; 1(9):R93-6. PubMed ID: 1669792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella. Surveillance to December 1990.
    Wkly Epidemiol Rec; 1991 Jul; 66(30):217-20. PubMed ID: 1911162
    [No Abstract]   [Full Text] [Related]  

  • 4. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The measles-mumps-rubella vaccination program in Finland.
    Redd SC; Wharton M; Hadler SC; Orenstein WA
    N Engl J Med; 1995 Apr; 332(16):1102-3. PubMed ID: 7898540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

  • 8. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
    Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella.
    Heath TC; Burgess MA; Forrest JM
    Commun Dis Intell; 1998 Aug; 22(8):157-8. PubMed ID: 9735550
    [No Abstract]   [Full Text] [Related]  

  • 11. Providing MMR vaccine to children.
    Orenstein WA; Plotkin S
    Minn Med; 1991 Mar; 74(3):7-8. PubMed ID: 2030684
    [No Abstract]   [Full Text] [Related]  

  • 12. MMR vaccine: a new initiative.
    Miller C
    Practitioner; 1989 Jan; 233(1461):63-4, 66. PubMed ID: 2798287
    [No Abstract]   [Full Text] [Related]  

  • 13. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A; Giorgi-Rossi P; Sangalli M; Spadea T; Perucci CA
    Ann Ig; 2002; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic.
    Ehrenkranz NJ; Ventura AK; Medler EM; Jackson JE; Kenny MT
    Bull World Health Organ; 1975; 52(1):81-5. PubMed ID: 764997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses of mentally retarded subjects to measles, mumps and rubella vaccines.
    Sinha SK; Carlson SD
    Wis Med J; 1975 Jul; 74(7):75-7. PubMed ID: 1163054
    [No Abstract]   [Full Text] [Related]  

  • 16. [Conjugated vaccine against measles, rubella and mumps].
    Vopr Virusol; 1989; 34(1):117-9. PubMed ID: 2728403
    [No Abstract]   [Full Text] [Related]  

  • 17. [Incubation vaccination ("post-exposure vaccination") with MMR vaccine during a mumps epidemic? The Pediatric Vaccine Counseling Unit].
    Wiersbitzky S; Bruns R; Beyer B
    Kinderarztl Prax; 1992 Oct; 60(7):207-8. PubMed ID: 1359187
    [No Abstract]   [Full Text] [Related]  

  • 18. MMR vaccine--one year on.
    Walker D
    Practitioner; 1990 May; 234(1489):550-2. PubMed ID: 2392406
    [No Abstract]   [Full Text] [Related]  

  • 19. Saliva antibody testing and vaccination in a mumps outbreak.
    Ramsay ME; Brown DW; Eastcott HR; Begg NT
    CDR (Lond Engl Rev); 1991 Aug; 1(9):R96-8. PubMed ID: 1669793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.